Latest news
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:08 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock TitanStock Titan · Thu, 06 Aug 2026 12:11:14 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTPriovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) - globenewswire.comglobenewswire.com · Thu, 06 Aug 2026 11:00:00 GMTInnovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2a-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 02:05:27 GMTInnovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 00:33:27 GMTSystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMTObsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 11:05:00 GMT